Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Viveve Medical Inc VIVE

Healthcare Medical Devices Medical Instruments & Supplies
Viveve Medical, Inc. designs, develops, manufactures and markets a platform medical technology, Cryogen-cooled Monopolar RadioFrequency (CMRF). The Company’s CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:VIVE)

Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence

Accesswire January 17, 2023

Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded

Accesswire December 15, 2022

Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

Accesswire December 1, 2022

Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Accesswire November 10, 2022

Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022

Accesswire October 27, 2022

Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence

Accesswire October 4, 2022

Viveve Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal PURSUIT Trial Readout

Accesswire September 27, 2022

Viveve to Participate in Ladenburg Thalmann Healthcare Conference

Accesswire September 22, 2022

Viveve to Participate in Alliance Global Partners Virtual MedTech Conference

Accesswire September 15, 2022
View More News ››

Opinion & Analysis (GREY:VIVE)

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming

Streetwise Reports May 16, 2019

Health Tech Firm Completes Enrollment for Female Sexual Function Trial

Streetwise Reports March 18, 2019

Analyst:'New CEO, Larger Sales Team and Greater SUI Focus Should Help Medical Device Growth'

Streetwise Reports May 23, 2018

Medical Device Firm Posts 'Strong Performance' Globally in Q4/17

Streetwise Reports March 28, 2018

Medical Device Firm to Launch Trials for Treatment Targeting $12 Billion Incontinence Market

Streetwise Reports February 14, 2018

Analysts say medical device firm sees record quarterly revenue growth, 120% YOY

Streetwise Reports November 29, 2017
View More Opinion ››

Bullboard Posts (GREY:VIVE)

VIVE ..... I was away camping

I missed all the action today (Monday) as it traded as high as $3.08 .....  +$0.70....it did close at $2.38 ....+$0.05 Still own...
Iseneschal - September 21, 2021

VIVE .... Possible and I repeat.....

Possible double bottom at $2.32 Time will tell Cheers
Iseneschal - September 17, 2021

VIVE ....adding on weakness

Cheers !
Iseneschal - September 15, 2021

VIVE ..... Price action

Thin to win
Iseneschal - September 9, 2021

VIVE .... I'm in some here

Rumor has it.......From the Gals I know ......say VIVE makes the best darn vibrators this side of the Pecos !!! Here's to Female...
Iseneschal - September 2, 2021

VIVE ..... still on watch

Now in Pull back mode Going to pick my spot to re-enter  Cheers 
Iseneschal - September 2, 2021
View more Bullboard ››

Star Diamond Corp

Star Diamond Corp

Star Diamond Corporation is a Canada-based company engaged in the acquisition, exploration and development of mineral ...
View More »